Note: Modified anvil design for improved reliability in DT-Cup experiments

The Deformation T-Cup (DT-Cup) is a modified 6-8 multi-anvil apparatus capable of controlled strain-rate deformation experiments at pressures greater than 18 GPa. Controlled strain-rate deformation was enabled by replacing two of the eight cubic "second-stage" anvils with hexagonal cross section deformation anvils and modifying the "first-stage" wedges. However, with these modifications approximately two-thirds of experiments end with rupture of the hexagonal anvils. By replacing the hexagonal anvils with cubic anvils and, split, deformation wedge extensions, we restore the massive support to the deformation anvils that were inherent in the original multi-anvil design and prevent deformation anvil failure. With the modified parts, the DT-Cup has an experimental success rate that is similar to that of a standard hydrostatic 6-8 multi-anvil apparatus

Phase diagram and thermal expansion of orthopyroxene-, clinopyroxene-, and ilmenite-structured MgGeO<inf>3</inf>

The MgGeO3 system is a low-pressure analog for the Earth-forming (Mg,Fe)SiO3 system and exhibits recoverable orthopyroxene, clinopyroxene, and ilmenite structures below 6 GPa. The pressure-temperature conditions of the clinopyroxene to ilmenite phase transition are reasonably consistent between studies, having a positive Clapeyron slope and occurring between 4 and 7 GPa in the temperature range 900-1600 K. There are, though, significant discrepancies in the Clapeyron slope of the orthopyroxene to clinopyroxene phase transition in existing works that also disagree on the stable phase at ambient conditions. The most significant factor in these differences is the method used; high-pressure experiments and thermophysical property measurements yield apparently contradicting results. Here, we perform both high pressure and temperature experiments as well as thermal expansion measurements to reconcile the measurements. High-pressure and -temperature experiments yield a Clapeyron slope of -1.0-+1.0-0.7 MPa/K for the MgGeO3 orthopyroxene-clinopyroxene phase transition, consistent with previous high-pressure and -temperature experiments. The MgGeO3 orthopyroxene-clinopyroxene-ilmenite triple point is determined to be at 0.98 GPa and 752 K, with the ilmenite phase stable at ambient conditions. The high-temperature (>600 K) thermal expansion of the clinopyroxene phase is greater than that of the other phases. Debye-Grüneisen relationships fitted to the volume-temperature data give Debye temperatures for the orthopyroxene, clinopyroxene, and ilmenite phases of 602(7), 693(10), and 758(13) K and V0 of 897.299(16), 433.192(10), and 289.156(6) Å3, respectively. The Clapeyron slopes calculated directly from the Debye-Grüneisen relationships are consistent with previous thermophysical property measurements. The presence of significant anharmonicity and/or formation of defects in the clinopyroxene phase at high-temperatures, which is not apparent in the other phases, accounts for the previous contradictions between studies. The inferred increased heat capacity of the clinopyroxene corresponds to an increase in entropy and an expanded phase field at high temperatures

The thermal expansion of (Fe1-y Ni y )Si

We have measured the thermal expansion of (Fe1-y Ni y )Si for y  =  0, 0.1 and 0.2, between 40 and 1273 K. Above ~700 K the unit-cell volumes of the samples decrease approximately linearly with increasing Ni content. Below ~200 K the unit-cell volume of FeSi falls to a value between that of (Fe0.9Ni0.1)Si and (Fe0.8Ni0.2)Si. We attribute this extra contraction of the FeSi, which is a narrow band-gap semiconductor, to the depopulation of the conduction band at low temperatures; in the two alloys the additional electrons introduced by the substitution of Ni lead to the conduction band always being populated. We have fit the unit-cell volume data with a Debye internal energy model of thermal expansion and an additional volume term, above 800 K, to take account of the volumetric changes associated with changes in the composition of the sample. Using the thermophysical parameters of the fit we have estimated the band gap in FeSi to be 21(1) meV and the unit-cell volume change in FeSi associated with the depopulation of the conduction band to be 0.066(35) Å(3)/unit-cell

The NiSi melting curve to 70 GPa

The melting curve of NiSi has been determined to 70 GPa on the basis of laser-heated diamond anvil cell (LH-DAC) experiments in which changes in the gradient of temperature vs. laser power functions were used as the melting criterion. The melting curve was corroborated with in situ X-ray diffraction experiments in both the LH-DAC and multi-anvil press in which the appearance of liquid diffuse scattering in the diffraction patterns was used as the melting criterion. At all pressures, the NiSi melting curve is lower than that of FeSi, with the difference in melting temperature reaching a maximum of 900 K at 14 GPa. The location of the B31 + B20 + L triple point has been constrained to 12 ± 2 GPa and 1550 ± 100 K and the B20 + B2 + L triple point to 28.5 ± 1.5 GPa and 2165 ± 60 K. On the basis of the in situ LH-DAC experiments the Clapeyron slope of the B20 → B2 transition is estimated at −67 MPa K−1. Extrapolation of the B2-NiSi liquidus to core-mantle boundary (CMB) conditions (135 GPa) suggests the melting point of NiSi (3700 ± 400 K) will be only marginally lower than that of isostructural FeSi (4000 ± 200 K). Thus any (Fe,Ni)Si solid solution present within the D″ layer is expected to remain solid, with the possible exception of the very hottest region adjacent to the CMB

Generic Mechanism of Emergence of Amyloid Protofilaments from Disordered Oligomeric aggregates

The presence of oligomeric aggregates, which is often observed during the process of amyloid formation, has recently attracted much attention since it has been associated with neurodegenerative conditions such as Alzheimer's and Parkinson's diseases. We provide a description of a sequence-indepedent mechanism by which polypeptide chains aggregate by forming metastable oligomeric intermediate states prior to converting into fibrillar structures. Our results illustrate how the formation of ordered arrays of hydrogen bonds drives the formation of beta-sheets within the disordered oligomeric aggregates that form early under the effect of hydrophobic forces. Initially individual beta-sheets form with random orientations, which subsequently tend to align into protofilaments as their lengths increases. Our results suggest that amyloid aggregation represents an example of the Ostwald step rule of first order phase transitions by showing that ordered cross-beta structures emerge preferentially from disordered compact dynamical intermediate assemblies.Comment: 14 pages, 4 figure

Biohydrogenation of 22:6n-3 by Butyrivibrio proteoclasticus P18

Background: Rumen microbes metabolize 22:6n-3. However, pathways of 22:6n-3 biohydrogenation and ruminal microbes involved in this process are not known. In this study, we examine the ability of the well-known rumen biohydrogenating bacteria, Butyrivibrio fibrisolvens D1 and Butyrivibrio proteoclasticus P18, to hydrogenate 22:6n-3. Results: Butyrivibrio fibrisolvens D1 failed to hydrogenate 22:6n-3 (0.5 to 32 mu g/mL) in growth medium containing autoclaved ruminal fluid that either had or had not been centrifuged. Growth of B. fibrisolvens was delayed at the higher 22:6n-3 concentrations; however, total volatile fatty acid production was not affected. Butyrivibrio proteoclasticus P18 hydrogenated 22:6n-3 in growth medium containing autoclaved ruminal fluid that either had or had not been centrifuged. Biohydrogenation only started when volatile fatty acid production or growth of B. proteoclasticus P18 had been initiated, which might suggest that growth or metabolic activity is a prerequisite for the metabolism of 22:6n-3. The amount of 22:6n-3 hydrogenated was quantitatively recovered in several intermediate products eluting on the gas chromatogram between 22:6n-3 and 22:0. Formation of neither 22:0 nor 22:6 conjugated fatty acids was observed during 22:6n-3 metabolism. Extensive metabolism was observed at lower initial concentrations of 22:6n-3 (5, 10 and 20 mu g/mL) whereas increasing concentrations of 22:6n-3 (40 and 80 mu g/mL) inhibited its metabolism. Stearic acid formation (18:0) from 18:2n-6 by B. proteoclasticus P18 was retarded, but not completely inhibited, in the presence of 22:6n-3 and this effect was dependent on 22:6n-3 concentration. Conclusions: For the first time, our study identified ruminal bacteria with the ability to hydrogenate 22:6n-3. The gradual appearance of intermediates indicates that biohydrogenation of 22:6n-3 by B. proteoclasticus P18 occurs by pathways of isomerization and hydrogenation resulting in a variety of unsaturated 22 carbon fatty acids. During the simultaneous presence of 18:2n-6 and 22:6n-3, B. proteoclasticus P18 initiated 22:6n-3 metabolism before converting 18:1 isomers into 18:0

On the increase in thermal diffusivity caused by the perovskite to post-perovskite phase transition and its implications for mantle dynamics

The thermal diffusivity (κ) of perovskite and post-perovskite CaIrO3 has been measured, at elevated pressure and temperatures up to 600 °C, using the X-radiographic Ångström method. At high temperatures we find that the thermal diffusivity of post-perovskite is slightly below twice that of isochemical perovskite over the temperature range investigated. Assuming a similar effect occurs in MgSiO3 post-perovskite, the effect of the contrasting thermal transport properties between perovskite and post-perovskite on mantle dynamics has been investigated using simple two-dimensional convection models. These show a reduction in extent and increase in depth of post-perovskite lenses, as well as increased core–mantle-boundary heat-flux, broader upwellings and more vigorous downwellings when compared to the reference, constant a, case

Enrichment of native plastic associated biofilm communities to enhance polyester degrading activity

Data Availability Statement: All data is available upon reasonable request to the corresponding author. Sequence data has been deposited in the NCBI SRA database and GenBank and is available under the code PRJNA962804.Supporting Information is available online at https://ami-journals.onlinelibrary.wiley.com/doi/full/10.1111/1462-2920.16466#support-information-section .Copyright © 2023 The Authors. Plastic pollution is an increasing worldwide problem urgently requiring a solution. While recycling rates are increasing globally, only 9% of all plastic waste has been recycled, and with the cost and limited downstream uses of recycled plastic, an alternative is needed. Here, we found that expanded polystyrene (EPS) promoted high levels of bacterial biofilm formation and sought out environmental EPS waste to characterize these native communities. We demonstrated that the EPS attached communities had limited plastic degrading activity. We then performed a long-term enrichment experiment where we placed a robust selection pressure on these communities by limiting carbon availability such that the waste plastic was the only carbon source. Seven of the resulting enriched bacterial communities had increased plastic degrading activity compared to the starting bacterial communities. Pseudomonas stutzeri was predominantly identified in six of the seven enriched communities as the strongest polyester degrader. Sequencing of one isolate of P. stutzeri revealed two putative polyesterases and one putative MHETase. This indicates that waste plastic-associated biofilms are a source for bacteria that have plastic-degrading potential, and that this potential can be unlocked through selective pressure and further in vitro enrichment experiments, resulting in biodegradative communities that are better than nature.Academy of Medical Sciences/the Wellcome Trust/the Government Department of Business, Energy and Industrial Strategy/the British Heart Foundation/Diabetes UK Springboard Award. Grant Number: SBF006/1040; Biotechnology and Biological Sciences Research Council New Investigator Award. Grant Number: BB/V007823/1; European Commission. Grant Number: 887648; Natural Environment Research Council. Grant Number: NE/X010902/1

Breast cancer risk reduction:is it feasible to initiate a randomised controlled trial of a lifestyle intervention programme (ActWell) within a national breast screening programme?

BackgroundBreast cancer is the most commonly diagnosed cancer and the second cause of cancer deaths amongst women in the UK. The incidence of the disease is increasing and is highest in women from least deprived areas. It is estimated that around 42% of the disease in post-menopausal women could be prevented by increased physical activity and reductions in alcohol intake and body fatness. Breast cancer control endeavours focus on national screening programmes but these do not include communications or interventions for risk reductionThis study aimed to assess the feasibility of delivery, indicative effects and acceptability of a lifestyle intervention programme initiated within the NHS Scottish Breast Screening Programme (NHSSBSP).MethodsA 1:1 randomised controlled trial (RCT) of the 3 month ActWell programme (focussing on body weight, physical activity and alcohol) versus usual care conducted in two NHSSBSP sites between June 2013 and January 2014. Feasibility assessments included recruitment, retention, and fidelity to protocol. Indicative outcomes were measured at baseline and 3 month follow-up (body weight, waist circumference, eating and alcohol habits and physical activity. At study end, a questionnaire assessed participant satisfaction and qualitative interviews elicited women¿s, coaches and radiographers¿ experiences. Statistical analysis used Chi squared tests for comparisons in proportions and paired t tests for comparisons of means. Linear regression analyses were performed, adjusted for baseline values, with group allocation as a fixed effectResultsA pre-set recruitment target of 80 women was achieved within 12 weeks and 65 (81%) participants (29 intervention, 36 control) completed 3 month assessments. Mean age was 58¿±¿5.6 years, mean BMI was 29.2¿±¿7.0 kg/m2 and many (44%) reported a family history of breast cancer.The primary analysis (baseline body weight adjusted) showed a significant between group difference favouring the intervention group of 2.04 kg (95%CI ¿3.24 kg to ¿0.85 kg). Significant, favourable between group differences were also detected for BMI, waist circumference, physical activity and sitting time. Women rated the programme highly and 70% said they would recommend it to others.ConclusionsRecruitment, retention, indicative results and participant acceptability support the development of a definitive RCT to measure long term effects.Trial registrationThe trial was registered with Current Controlled Trials (ISRCTN56223933)

Influence of specific HSP70 domains on fibril formation of the yeast prion protein Ure2.

Ure2p is the protein determinant of the Saccharomyces cerevisiae prion state [URE3]. Constitutive overexpression of the HSP70 family member SSA1 cures cells of [URE3]. Here, we show that Ssa1p increases the lag time of Ure2p fibril formation in vitro in the presence or absence of nucleotide. The presence of the HSP40 co-chaperone Ydj1p has an additive effect on the inhibition of Ure2p fibril formation, whereas the Ydj1p H34Q mutant shows reduced inhibition alone and in combination with Ssa1p. In order to investigate the structural basis of these effects, we constructed and tested an Ssa1p mutant lacking the ATPase domain, as well as a series of C-terminal truncation mutants. The results indicate that Ssa1p can bind to Ure2p and delay fibril formation even in the absence of the ATPase domain, but interaction of Ure2p with the substrate-binding domain is strongly influenced by the C-terminal lid region. Dynamic light scattering, quartz crystal microbalance assays, pull-down assays and kinetic analysis indicate that Ssa1p interacts with both native Ure2p and fibril seeds, and reduces the rate of Ure2p fibril elongation in a concentration-dependent manner. These results provide new insights into the structural and mechanistic basis for inhibition of Ure2p fibril formation by Ssa1p and Ydj1p